US stock · Healthcare sector · Medical Care Facilities
Company Logo

DaVita Inc.

DVANYSE

82.77

USD
-1.19
(-1.42%)
Market Closed
10.70P/E
8Forward P/E
0.53P/E to S&P500
7.557BMarket CAP
- -Div Yield
Upcoming Earnings
26 Oct-31 Oct
Shares Short
Short % of Float
- -
Short % of Shares Outs.
- -
% Held by Insiders
- -
% Held by Institutions
- -
Beta
1.14
PEG Ratio
- -
52w. high/low
124.81/74.97
Avg. Daily Volume
0.74M
Return %
Stock
S&P 500
1 year
(29.50)
(16.20)
3 years
47.58
22.35
5 years
42.06
44.82
Scale: |
High
Low
33.72
25.38
30.11
20.48
30.98
20.61
37.30
28.29
44.88
29.57
58.25
38.30
65.67
52.75
78.52
62.52
85.17
67.34
78.77
54.50
72.93
52.51
80.71
48.25
75.30
43.40
117.65
62.20
136.48
94.38
124.81
74.97
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
23.57
24.86
26.91
29.48
31.76
36.88
42.63
56.04
60.27
65.05
73.13
57.66
66.78
74.35
96.42
110.41
117.29
Earnings per share
1.40
1.80
1.78
2.04
2.00
2.52
2.79
3.02
3.41
1.27
4.36
3.52
0.93
5.29
6.46
9.30
8.40
FCF per share
1.21
1.22
1.13
1.89
2.79
4.12
2.87
5.51
3.85
4.01
5.63
5.31
4.59
8.52
10.89
12.25
10.03
Dividends per share
- -
- -
- -
0.33
0.41
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
1.30
1.30
1.51
1.33
1.35
2.11
2.86
2.94
3.03
3.34
4.11
4.80
5.78
5.00
5.63
6.10
6.18
Book Value per sh.
6.02
8.18
9.28
10.30
9.75
11.31
19.60
21.11
24.35
22.99
23.05
24.86
21.68
13.93
11.55
7.18
8.46
Comm.Shares outs.
207
212
210
207
203
189
192
210
212
212
202
189
171
153
120
105
99
Avg. annual P/E ratio
19.6
15.7
14.6
12.4
16.2
15.4
17.0
19.5
20.9
60.6
15.8
18.1
73.6
10.8
13.3
12.4
10.7
P/E to S&P500
1.1
0.9
0.7
0.2
0.8
0.9
1.1
1.1
1.2
3.0
0.7
0.8
2.9
0.4
0.4
0.4
0.5
Avg. annual div. yield
- -
- -
- -
1.3%
1.3%
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
4,881
5,264
5,660
6,109
6,447
6,982
8,186
11,764
12,795
13,782
14,745
10,877
11,405
11,388
11,551
11,619
11,627
Operating margin
15.2%
16.4%
14.5%
15.4%
15.5%
16.2%
15.8%
13.2%
14.2%
8.5%
12.8%
16.7%
13.4%
14.4%
14.7%
15.5%
14.0%
Depreciation (m)
173
193
217
229
234
267
344
528
591
638
720
777
591
615
630
681
689
Net profit (m)
290
382
374
423
406
478
536
633
723
270
880
664
159
811
774
978
834
Income tax rate
39.2%
39.2%
38.6%
36.7%
35.0%
35.4%
35.9%
33.9%
34.1%
40.9%
30.6%
23.1%
24.6%
23.4%
23.8%
20.2%
20.0%
Net profit margin
5.9%
7.3%
6.6%
6.9%
6.3%
6.8%
6.5%
5.4%
5.7%
2.0%
6.0%
6.1%
1.4%
7.1%
6.7%
8.4%
7.2%
Working capital (m)
597
890
965
1,256
1,699
1,128
861
1,010
1,788
2,104
1,284
5,703
3,533
1,318
673
769
953
Long-term debt (m)
3,730
3,684
3,622
3,563
4,234
4,418
8,327
8,141
8,383
9,001
8,947
9,158
8,173
7,978
10,656
11,402
11,671
Equity (m)
1,246
1,732
1,952
2,135
1,978
2,141
3,763
4,432
5,171
4,871
4,648
4,690
3,703
2,133
1,384
756
605
ROIC
5.5%
6.7%
6.3%
8.7%
7.7%
8.8%
5.5%
6.6%
6.6%
3.6%
7.7%
6.9%
4.9%
8.0%
7.4%
8.6%
8.4%
Return on capital
7.5%
9.2%
8.6%
11.8%
10.5%
11.8%
7.5%
8.5%
8.9%
5.3%
9.4%
7.6%
4.8%
9.0%
8.3%
9.3%
9.0%
Return on equity
23.3%
22.0%
19.2%
19.8%
20.5%
22.3%
14.2%
14.3%
14.0%
5.5%
18.9%
14.1%
4.3%
38.0%
55.9%
129.5%
137.9%
Plowback ratio
100.0%
100.0%
100.0%
84.0%
79.4%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
(16.2)%
(21.9)%
80.9%
52.5%
124.0%
41.5%
- -
- -
- -
64.8%
96.8%
80.1%
148.1%
182.6%
111.9%
124.0%
166.9%
Capital Structure
1 Aug · 2022 | Q2
All numbers in millions
Total liabilities
$ 14,940
Total assets
$ 17,101
Long-term debt
$ 11,671
Cash and equiv.
$ 263
Goodwill
$ 7,020
Retained earnings
$ 741
Common stock
94
Enterprise Value
$ 18,966
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
1,114
345
484
Receivables
2,305
2,439
2,411
Inventory
98
112
107
Other
173
(524)
(475)
Current assets
3,690
3,149
3,168
Acc. Payable
404
434
402
Debt due
475
538
573
Other
1,494
1,504
1,423
Current liabilities
2,372
2,476
2,399
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
0.59%
1.68%
5.30%
Cash flow
(1.16)%
10.87%
16.66%
Earnings
26.47%
88.67%
58.44%
Dividends
- -
- -
- -
Book value
(45.39)%
(35.99)%
(13.22)%
Insider Trading
Type
Shares
Date
Arway Pamela M
Award
514
08/15/22
Berg Charles
Award
514
08/15/22
Desoer Barbara J
Award
514
08/15/22
Diaz Paul J
Award
514
08/15/22
Hollar Jason M.
Award
317
08/15/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
2,841
2,880
2,924
2,905
11,551
2021
2,820
2,917
2,938
2,944
11,619
2022
2,818
2,927
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
2.00
1.68
1.32
1.45
6.46
2021
2.26
2.79
2.47
1.78
9.30
2022
1.68
2.38
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Care Facilities
CEO:
Mr. Javier Rodriguez
Full-time employees:
69,000
City:
Denver
Address:
2000 16th St
IPO:
Oct 31, 1995
Website:
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Recent News
· 16 Apr, 2022 · The Wall Street Journal